Infants With Very High Risk KMT2A B-ALL
1 clinical trials · Condition
◉ Watch Infants With Very High Risk KMT2A B-ALL
| Record | Firm | Date |
|---|---|---|
| Orphan Indications for CD19 Redirected Autologous T Cells (NCT04276870) | Stephan Grupp MD PhD | 2020-03-12 |
Track Infants With Very High Risk KMT2A B-ALL automatically
Every clearance here is in the API, with alerts when new ones post.